{"id":"https://openalex.org/W7203737559","doi":"https://doi.org/10.1016/j.adro.2026.102174","title":"Neoadjuvant Chemotherapy Increases Genomic Radioresistance in Hormone Receptor\u2013positive, Human Epidermal Growth Factor Receptor 2\u2013Negative Breast Cancer: Implications for Radiation Sensitivity Index/Genomic-Adjusted Radiation Dose\u2013Guided Radiation Therapy Personalization","display_name":"Neoadjuvant Chemotherapy Increases Genomic Radioresistance in Hormone Receptor\u2013positive, Human Epidermal Growth Factor Receptor 2\u2013Negative Breast Cancer: Implications for Radiation Sensitivity Index/Genomic-Adjusted Radiation Dose\u2013Guided Radiation Therapy Personalization","publication_year":2026,"publication_date":"2026-08-19","ids":{"openalex":"https://openalex.org/W7203737559","doi":"https://doi.org/10.1016/j.adro.2026.102174","pmid":"https://pubmed.ncbi.nlm.nih.gov/42936472","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13698056"},"language":"en","primary_location":{"id":"doi:10.1016/j.adro.2026.102174","doi":"https://doi.org/10.1016/j.adro.2026.102174","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.adro.2026.102174","pdf_url":null,"source":{"id":"https://openalex.org/S2765008485","display_name":"Advances in Radiation Oncology","issn_l":"2452-1094","issn":["2452-1094"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Radiation Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.adro.2026.102174","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063104455","display_name":"Pierre Loap","orcid":"https://orcid.org/0000-0001-8863-8110","observed_orcids":["https://orcid.org/0000-0001-8863-8110"]},"institutions":[{"id":"https://openalex.org/I4405266781","display_name":"Imagerie, Radioth\u00e9rapie Innovante et m\u00e9decine des Syst\u00e8mes","ror":"https://ror.org/05h75s094","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I195731000","https://openalex.org/I277688954","https://openalex.org/I4405266781","https://openalex.org/I80043"]},{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Pierre Loap","raw_affiliation_strings":["Department of Radiation Oncology, Institut Curie, Paris, France","Innovative Radiotherapy and Systems Medicine Laboratory (IRIS), U1353 / UMR 9029, Institut Curie, Orsay, France","Proton Therapy Center (CPO), Institut Curie, Orsay, France"],"raw_orcid":"https://orcid.org/0000-0001-8863-8110","affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, Institut Curie, Paris, France","institution_ids":["https://openalex.org/I80043"]},{"raw_affiliation_string":"Innovative Radiotherapy and Systems Medicine Laboratory (IRIS), U1353 / UMR 9029, Institut Curie, Orsay, France","institution_ids":["https://openalex.org/I4405266781","https://openalex.org/I80043"]},{"raw_affiliation_string":"Proton Therapy Center (CPO), Institut Curie, Orsay, France","institution_ids":["https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054669965","display_name":"G. Cr\u00e9hange","orcid":"https://orcid.org/0000-0002-7127-9323","observed_orcids":["https://orcid.org/0000-0002-7127-9323"]},"institutions":[{"id":"https://openalex.org/I4405266781","display_name":"Imagerie, Radioth\u00e9rapie Innovante et m\u00e9decine des Syst\u00e8mes","ror":"https://ror.org/05h75s094","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I195731000","https://openalex.org/I277688954","https://openalex.org/I4405266781","https://openalex.org/I80043"]},{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Gilles Crehange","raw_affiliation_strings":["Department of Radiation Oncology, Institut Curie, Paris, France","Innovative Radiotherapy and Systems Medicine Laboratory (IRIS), U1353 / UMR 9029, Institut Curie, Orsay, France","Proton Therapy Center (CPO), Institut Curie, Orsay, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, Institut Curie, Paris, France","institution_ids":["https://openalex.org/I80043"]},{"raw_affiliation_string":"Innovative Radiotherapy and Systems Medicine Laboratory (IRIS), U1353 / UMR 9029, Institut Curie, Orsay, France","institution_ids":["https://openalex.org/I4405266781","https://openalex.org/I80043"]},{"raw_affiliation_string":"Proton Therapy Center (CPO), Institut Curie, Orsay, France","institution_ids":["https://openalex.org/I80043"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5012593402","display_name":"Youlia Kirova","orcid":"https://orcid.org/0000-0002-1795-7509","observed_orcids":["https://orcid.org/0000-0002-1795-7509"]},"institutions":[{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Youlia Kirova","raw_affiliation_strings":["Department of Radiation Oncology, Institut Curie, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiation Oncology, Institut Curie, Paris, France","institution_ids":["https://openalex.org/I80043"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5063104455"],"corresponding_institution_ids":["https://openalex.org/I4405266781","https://openalex.org/I80043"],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":{"value":2500,"currency":"USD","value_usd":2500},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.52644309,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"11","issue":"12","first_page":"102174","last_page":"102174"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10358","display_name":"Advanced Radiotherapy Techniques","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/3108","display_name":"Radiation"},"field":{"id":"https://openalex.org/fields/31","display_name":"Physics and Astronomy"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11359","display_name":"Effects of Radiation Exposure","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.9819999933242798},{"id":"https://openalex.org/keywords/hr-her2-breast-cancer","display_name":"hormone receptor-positive HER2-negative breast cancer","score":0.8479999899864197},{"id":"https://openalex.org/keywords/tumor-immune-microenvironment","display_name":"tumor immune microenvironment","score":0.6439999938011169},{"id":"https://openalex.org/keywords/m2-macrophages","display_name":"M2 macrophages","score":0.9079999923706055},{"id":"https://openalex.org/keywords/rna-sequencing","display_name":"RNA sequencing","score":0.4860000014305115},{"id":"https://openalex.org/keywords/fractionation-schedule","display_name":"fractionation schedule","score":0.5440000295639038}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9175000190734863},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6908000111579895},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6743000149726868},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.6705999970436096},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6547999978065491},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.507099986076355},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.48829999566078186},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.47589999437332153},{"id":"https://openalex.org/C2777757722","wikidata":"https://www.wikidata.org/wiki/Q848318","display_name":"Mastectomy","level":4,"score":0.43619999289512634},{"id":"https://openalex.org/C58962609","wikidata":"https://www.wikidata.org/wiki/Q2353022","display_name":"Radioresistance","level":3,"score":0.41119998693466187},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.3952000141143799},{"id":"https://openalex.org/C3018454096","wikidata":"https://www.wikidata.org/wiki/Q2481887","display_name":"Adjuvant radiotherapy","level":3,"score":0.3898000121116638},{"id":"https://openalex.org/C2778311097","wikidata":"https://www.wikidata.org/wiki/Q5903784","display_name":"Hormonal therapy","level":4,"score":0.38269999623298645},{"id":"https://openalex.org/C2780275930","wikidata":"https://www.wikidata.org/wiki/Q1628266","display_name":"Hormone therapy","level":4,"score":0.3799000084400177},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3716999888420105},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.31220000982284546},{"id":"https://openalex.org/C2781467025","wikidata":"https://www.wikidata.org/wiki/Q4959754","display_name":"Breast-conserving surgery","level":5,"score":0.28949999809265137},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.2800999879837036},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.266400009393692},{"id":"https://openalex.org/C155806632","wikidata":"https://www.wikidata.org/wiki/Q5299253","display_name":"Dose fractionation","level":3,"score":0.26589998602867126},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.2524999976158142},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.25220000743865967}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1016/j.adro.2026.102174","doi":"https://doi.org/10.1016/j.adro.2026.102174","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.adro.2026.102174","pdf_url":null,"source":{"id":"https://openalex.org/S2765008485","display_name":"Advances in Radiation Oncology","issn_l":"2452-1094","issn":["2452-1094"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Radiation Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13698056","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13698056/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13698056/pdf/main.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Adv Radiat Oncol","raw_type":"Text"},{"id":"pmid:42936472","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42936472","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in radiation oncology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:26578670cb81418ebd495172fab32047","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/26578670cb81418ebd495172fab32047","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Advances in Radiation Oncology, Vol 11, Iss 12, Pp 102174- (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.adro.2026.102174","doi":"https://doi.org/10.1016/j.adro.2026.102174","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.adro.2026.102174","pdf_url":null,"source":{"id":"https://openalex.org/S2765008485","display_name":"Advances in Radiation Oncology","issn_l":"2452-1094","issn":["2452-1094"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","jufo-1","ki-jl-1","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in Radiation Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7203737559.pdf","grobid_xml":"https://content.openalex.org/works/W7203737559.grobid-xml"},"referenced_works_count":17,"referenced_works":["https://openalex.org/W1926432155","https://openalex.org/W2050034556","https://openalex.org/W2073611256","https://openalex.org/W2075894019","https://openalex.org/W2566074209","https://openalex.org/W2947554843","https://openalex.org/W2967297026","https://openalex.org/W3122861570","https://openalex.org/W3192108828","https://openalex.org/W4229013531","https://openalex.org/W4307148831","https://openalex.org/W4388278686","https://openalex.org/W4391723488","https://openalex.org/W4413805693","https://openalex.org/W4414558013","https://openalex.org/W4415179643","https://openalex.org/W7128598267"],"related_works":["https://openalex.org/W4413805693","https://openalex.org/W4396586776","https://openalex.org/W2400238020","https://openalex.org/W3094085867","https://openalex.org/W2402062726","https://openalex.org/W7162856259","https://openalex.org/W2566074209","https://openalex.org/W3164674987","https://openalex.org/W2806290426","https://openalex.org/W2912019902"],"abstract_inverted_index":{"Purpose:":[0],"Adjuvant":[1],"radiation":[2,27,33,42,66,156,223],"therapy":[3,43,157,224],"(RT)":[4],"improves":[5],"locoregional":[6],"control":[7],"after":[8,210],"breast":[9,94,196],"cancer":[10,95],"surgery,":[11],"but":[12],"dose":[13,34,178],"prescription":[14],"remains":[15],"based":[16],"mainly":[17],"on":[18,52],"clinicopathologic":[19],"risk":[20],"rather":[21],"than":[22],"individual":[23],"tumor":[24],"radiosensitivity.":[25],"The":[26,100,120,129,171],"sensitivity":[28],"index":[29],"(RSI)":[30],"and":[31,69,75,109,143,153],"genomic-adjusted":[32],"(GARD)":[35],"provide":[36],"a":[37,125,168,189],"framework":[38],"for":[39,148,220],"biologically":[40],"guided":[41],"personalization.":[44],"In":[45],"the":[46,53,59,110,144,207],"neoadjuvant":[47,98],"setting,":[48],"however,":[49],"radiosensitivity":[50],"measured":[51],"diagnostic":[54],"biopsy":[55],"may":[56,202],"not":[57],"reflect":[58],"residual":[60,200],"disease":[61],"ultimately":[62],"targeted":[63],"by":[64],"adjuvant":[65,155,222],"therapy.":[67,212],"Methods":[68],"Materials:":[70],"We":[71],"analyzed":[72],"matched":[73,105,115],"pretreatment":[74,162],"posttreatment":[76],"RNA":[77],"sequencing":[78],"data":[79],"from":[80,107,118],"2":[81],"public":[82],"cohorts":[83],"of":[84],"hormone":[85],"receptor-positive,":[86],"human":[87],"epidermal":[88],"growth":[89],"factor":[90],"receptor":[91],"2-negative":[92],"(HR+/HER2-)":[93],"treated":[96],"with":[97,167,188],"chemotherapy.":[99],"discovery":[101],"cohort":[102,112],"included":[103,113],"16":[104],"pairs":[106,117],"GSE191127,":[108],"validation":[111],"14":[114],"HR+/HER2-":[116,195],"GSE309004.":[119],"RSI":[121,172,193,216],"was":[122,131,146],"computed":[123],"using":[124,141],"10-gene":[126],"rank-based":[127],"model.":[128],"\u0394RSI":[130],"defined":[132],"as":[133],"RSI_post":[134],"-":[135],"RSI_pre.":[136],"Immune":[137],"fractions":[138],"were":[139],"inferred":[140],"quanTIseq,":[142],"GARD":[145,177],"calculated":[147],"START":[149],"B,":[150],"RTOG":[151],"1005,":[152],"FAST-Forward":[154],"schedules.":[158,182],"Results:":[159],"005).":[160],"Higher":[161],"M2":[163],"macrophage":[164],"fraction":[165],"correlated":[166],"larger":[169],"\u0394RSI.":[170],"changes":[173],"translated":[174],"into":[175],"heterogeneous":[176],"modifications":[179],"across":[180],"fractionation":[181],"Conclusions:":[183],"Neoadjuvant":[184],"chemotherapy":[185,215],"is":[186],"associated":[187],"reproducible":[190],"increase":[191],"in":[192,194],"cancer,":[197],"suggesting":[198],"that":[199],"tumors":[201],"become":[203],"more":[204],"radioresistant":[205],"at":[206],"genomic":[208],"level":[209],"systemic":[211],"A":[213],"postneoadjuvant":[214],"warrants":[217],"prospective":[218],"evaluation":[219],"individualized":[221],"strategies.":[225]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-08-20T00:00:00"}